Elantas Beck India Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 11, 2025, 10:47 pm

Market Cap	7,837 Cr.
Current Price	9,886
High / Low	14,980/7,601
Stock P/E	56.2
Book Value	1,094
Dividend Yield	0.05 %
ROCE	23.0 %
ROE	17.4 %
Face Value	10.0
PEG Ratio	3.17

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Elantas Beck India Ltd

Competitors of Elantas Beck India Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujchem Distillers India Ltd	110 Cr.	307	541/73.0		390	0.00 %	1.38 %	2.17 %	1.00
Elantas Beck India Ltd	7,837 Cr.	9,886	14,980/7,601	56.2	1,094	0.05 %	23.0 %	17.4 %	10.0
Crestchem Ltd	72.9 Cr.	243	350/107	26.2	21.1	0.21 %	78.2 %	56.2 %	10.0
Chemiesynth (Vapi) Ltd	11.0 Cr.	35.8	34.1/0.00		37.5	0.00 %	1.00 %	3.38 %	10.0
Archit Organosys Ltd	93.0 Cr.	45.3	61.0/34.2	42.5	32.2	0.00 %	3.69 %	0.75 %	10.0
Industry Average	4,901.50 Cr	1,616.05		56.58	325.78	0.32%	15.97%	12.07%	7.41

All Competitor Stocks of Elantas Beck India Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	146	156	171	153	165	169	173	163	174	177	191	184	197
Expenses	124	126	141	129	136	134	138	126	138	139	153	150	162
Operating Profit	22	30	30	24	29	36	35	37	36	38	39	33	35
OPM %	15%	19%	17%	16%	17%	21%	20%	23%	20%	21%	20%	18%	18%
Other Income	4	4	1	14	10	8	15	12	17	15	17	12	10
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	3	3	3	3	3	3	3	3	3	3	3	4	5
Profit before tax	22	31	28	35	35	40	47	47	49	49	52	42	40
Tax %	26%	24%	26%	22%	25%	26%	25%	25%	25%	25%	20%	25%	26%
Net Profit	17	24	21	27	26	30	35	35	37	37	42	31	30
EPS in Rs	20.94	29.91	25.95	34.07	33.40	37.91	44.68	43.93	46.67	46.56	52.79	39.19	37.51

Last Updated: February 28, 2025, 11:54 am

Below is a detailed analysis of the quarterly data for Elantas Beck India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹197.00 Cr.. The value appears strong and on an upward trend. It has increased from 184.00 Cr. (Sep 2024) to ₹197.00 Cr., marking an increase of ₹13.00 Cr..
For Expenses, as of Dec 2024, the value is ₹162.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 150.00 Cr. (Sep 2024) to ₹162.00 Cr., marking an increase of ₹12.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹35.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Sep 2024) to ₹35.00 Cr., marking an increase of ₹2.00 Cr..
For OPM %, as of Dec 2024, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 18.00%.
For Other Income, as of Dec 2024, the value is ₹10.00 Cr.. The value appears to be declining and may need further review. It has decreased from 12.00 Cr. (Sep 2024) to ₹10.00 Cr., marking a decrease of 2.00 Cr..
For Interest, as of Dec 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹5.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.00 Cr. (Sep 2024) to ₹5.00 Cr., marking an increase of ₹1.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 42.00 Cr. (Sep 2024) to ₹40.00 Cr., marking a decrease of 2.00 Cr..
For Tax %, as of Dec 2024, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 26.00%, marking an increase of 1.00%.
For Net Profit, as of Dec 2024, the value is ₹30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 31.00 Cr. (Sep 2024) to ₹30.00 Cr., marking a decrease of 1.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 37.51. The value appears to be declining and may need further review. It has decreased from ₹39.19 (Sep 2024) to 37.51, marking a decrease of ₹1.68.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 1:15 pm

Metric	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales	304	341	344	365	383	409	394	383	522	645	680	749
Expenses	265	299	282	287	304	344	340	313	444	535	537	604
Operating Profit	39	42	62	79	78	65	54	70	78	110	143	144
OPM %	13%	12%	18%	22%	20%	16%	14%	18%	15%	17%	21%	19%
Other Income	11	8	6	8	9	31	18	22	25	32	53	55
Interest	0	0	0	0	0	0	0	0	0	1	1	1
Depreciation	5	5	6	5	6	7	7	12	12	12	12	15
Profit before tax	45	45	62	81	81	89	64	80	91	129	184	183
Tax %	29%	30%	32%	33%	32%	26%	22%	23%	27%	24%	25%	24%
Net Profit	32	32	42	54	55	66	50	62	67	98	137	140
EPS in Rs	40.05	39.87	52.68	68.73	69.48	82.99	62.51	77.90	84.36	123.34	173.19	176.04
Dividend Payout %	137%	11%	9%	7%	6%	5%	8%	6%	6%	4%	3%	4%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:	8%
5 Years:	14%
3 Years:	13%
TTM:	10%

Compounded Profit Growth
10 Years:	17%
5 Years:	23%
3 Years:	33%
TTM:	2%

Stock Price CAGR
10 Years:	24%
5 Years:	32%
3 Years:	44%
1 Year:	23%

Return on Equity
10 Years:	18%
5 Years:	17%
3 Years:	18%
Last Year:	17%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Jun 2024
Equity Capital	8	8	8	8	8	8	8	8	8	8	8	8	8
Reserves	120	100	128	164	214	270	331	376	434	497	591	724	799
Borrowings	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	127	93	57	64	70	70	76	72	95	114	119	149	158
Total Liabilities	255	201	192	236	291	348	415	456	536	618	717	881	965
Fixed Assets	49	48	45	45	36	40	70	110	103	98	98	99	172
CWIP	0	0	1	0	5	15	0	10	18	19	13	17	11
Investments	100	45	30	64	109	139	174	160	218	261	356	517	227
Other Assets	105	108	116	126	140	154	171	176	198	240	250	247	555
Total Assets	255	201	192	236	291	348	415	456	536	618	717	881	965

Below is a detailed analysis of the balance sheet data for Elantas Beck India Ltd based on the most recent figures (Jun 2024) and their trends compared to the previous period:

For Equity Capital, as of Jun 2024, the value is ₹8.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2023) which recorded ₹8.00 Cr..
For Reserves, as of Jun 2024, the value is ₹799.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹724.00 Cr. (Dec 2023) to ₹799.00 Cr., marking an increase of 75.00 Cr..
For Borrowings, as of Jun 2024, the value is ₹0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Dec 2023) which recorded ₹0.00 Cr..
For Other Liabilities, as of Jun 2024, the value is ₹158.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹149.00 Cr. (Dec 2023) to ₹158.00 Cr., marking an increase of 9.00 Cr..
For Total Liabilities, as of Jun 2024, the value is ₹965.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹881.00 Cr. (Dec 2023) to ₹965.00 Cr., marking an increase of 84.00 Cr..
For Fixed Assets, as of Jun 2024, the value is ₹172.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹99.00 Cr. (Dec 2023) to ₹172.00 Cr., marking an increase of 73.00 Cr..
For CWIP, as of Jun 2024, the value is ₹11.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹17.00 Cr. (Dec 2023) to ₹11.00 Cr., marking a decrease of 6.00 Cr..
For Investments, as of Jun 2024, the value is ₹227.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹517.00 Cr. (Dec 2023) to ₹227.00 Cr., marking a decrease of 290.00 Cr..
For Other Assets, as of Jun 2024, the value is ₹555.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹247.00 Cr. (Dec 2023) to ₹555.00 Cr., marking an increase of 308.00 Cr..
For Total Assets, as of Jun 2024, the value is ₹965.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹881.00 Cr. (Dec 2023) to ₹965.00 Cr., marking an increase of 84.00 Cr..

Notably, the Reserves (₹799.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operating Activity +	23	31	46	56	51	33	48	79	29	83	133	63
Cash from Investing Activity +	62	19	-42	-51	-45	-32	-40	-69	-33	-76	-132	78
Cash from Financing Activity +	-85	-51	-4	-5	-5	-4	-5	-4	-4	-5	-5	-5
Net Cash Flow	-0	-2	0	0	2	-3	4	6	-8	2	-3	136

Free Cash Flow

Month	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Free Cash Flow	39.00	42.00	62.00	79.00	78.00	65.00	54.00	70.00	78.00	110.00	143.00	144.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023
Debtor Days	51	56	53	59	53	70	75	57	67	61	58	55
Inventory Days	90	81	84	85	100	75	74	77	89	95	73	68
Days Payable	51	44	55	64	73	73	71	56	103	86	67	81
Cash Conversion Cycle	90	93	82	80	80	71	78	77	54	70	64	41
Working Capital Days	-44	9	58	55	55	62	69	59	46	57	48	33
ROCE %	20%	34%	35%	40%	41%	33%	23%	18%	19%	17%	22%	28%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Promoters	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%	75.00%
FIIs	3.99%	4.00%	3.76%	3.67%	0.82%	0.80%	0.74%	0.73%	0.71%	0.70%	0.67%	0.67%
DIIs	7.98%	8.35%	8.59%	8.59%	11.31%	11.44%	11.50%	11.73%	11.80%	11.88%	11.91%	11.88%
Public	13.03%	12.65%	12.65%	12.75%	12.87%	12.75%	12.76%	12.54%	12.49%	12.42%	12.43%	12.44%
No. of Shareholders	7,448	7,392	7,088	7,155	7,145	7,283	7,475	7,578	7,526	7,541	7,786	8,667

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Nippon India Small Cap Fund	614,625	1.39	716.94	321	2025-03-11	191371.96%
Tata Small Cap Fund	215,767	3.55	251.68	321	2025-03-11	67117.13%
Tata Large & Mid Cap Fund - Regular Plan	102,551	1.64	119.62	321	2025-03-11	31847.35%
Tata Large & Mid Cap Fund - Regular Plan	102,551	1.64	119.62	321	2025-03-11	31847.35%
Union Small Cap Fund	7,314	0.6	8.53	321	2025-03-11	2178.5%
Union Retirement Fund	1,300	1.2	1.52	321	2025-03-11	304.98%
Union Childrens Fund	441	1.1	0.51	321	2025-03-11	37.38%
Union Equity Savings Fund	321	0.3	0.37	321	2025-03-11	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	173.18	123.34	84.36	77.91	62.52
Diluted EPS (Rs.)	173.18	123.34	84.36	77.91	62.52
Cash EPS (Rs.)	188.19	138.97	99.64	92.67	71.79
Book Value[Excl.RevalReserv]/Share (Rs.)	923.34	755.07	636.59	557.02	484.41
Book Value[Incl.RevalReserv]/Share (Rs.)	923.34	755.07	636.59	557.02	484.41
Dividend / Share (Rs.)	5.00	5.00	5.00	5.00	5.00
Revenue From Operations / Share (Rs.)	857.61	813.23	658.62	483.28	497.07
PBDIT / Share (Rs.)	247.35	165.77	119.32	116.22	90.16
PBIT / Share (Rs.)	232.34	150.14	104.05	101.46	80.89
PBT / Share (Rs.)	231.62	162.89	115.26	101.18	80.46
Net Profit / Share (Rs.)	173.18	123.34	84.36	77.91	62.52
PBDIT Margin (%)	28.84	20.38	18.11	24.04	18.13
PBIT Margin (%)	27.09	18.46	15.79	20.99	16.27
PBT Margin (%)	27.00	20.02	17.50	20.93	16.18
Net Profit Margin (%)	20.19	15.16	12.80	16.12	12.57
Return on Networth / Equity (%)	18.75	16.33	13.25	13.98	12.90
Return on Capital Employeed (%)	24.34	19.24	15.79	17.63	16.18
Return On Assets (%)	15.59	13.62	10.81	11.51	10.86
Asset Turnover Ratio (%)	0.85	0.96	0.90	0.77	0.90
Current Ratio (X)	6.12	5.92	4.75	4.65	5.11
Quick Ratio (X)	5.53	5.11	3.87	3.99	4.28
Inventory Turnover Ratio (X)	5.40	5.21	5.25	4.18	5.07
Dividend Payout Ratio (NP) (%)	2.88	4.05	5.92	6.41	7.19
Dividend Payout Ratio (CP) (%)	2.65	3.59	5.01	5.39	6.26
Earning Retention Ratio (%)	97.12	95.95	94.08	93.59	92.81
Cash Earning Retention Ratio (%)	97.35	96.41	94.99	94.61	93.74
Interest Coverage Ratio (X)	343.36	212.79	379.45	422.05	211.54
Interest Coverage Ratio (Post Tax) (X)	241.41	141.97	232.60	283.93	147.67
Enterprise Value (Cr.)	6676.60	3404.85	2895.59	2157.70	1935.04
EV / Net Operating Revenue (X)	9.82	5.28	5.55	5.63	4.91
EV / EBITDA (X)	34.05	25.91	30.61	23.42	27.07
MarketCap / Net Operating Revenue (X)	9.90	5.35	5.58	5.70	4.97
Retention Ratios (%)	97.11	95.94	94.07	93.58	92.80
Price / BV (X)	9.20	5.76	5.77	4.95	5.10
Price / Net Operating Revenue (X)	9.90	5.35	5.58	5.70	4.97
EarningsYield	0.02	0.02	0.02	0.02	0.02

After reviewing the key financial ratios for Elantas Beck India Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Dec 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Dec 22) which recorded 10.00.
For Basic EPS (Rs.), as of Dec 23, the value is 173.18. This value is within the healthy range. It has increased from 123.34 (Dec 22) to 173.18, marking an increase of 49.84.
For Diluted EPS (Rs.), as of Dec 23, the value is 173.18. This value is within the healthy range. It has increased from 123.34 (Dec 22) to 173.18, marking an increase of 49.84.
For Cash EPS (Rs.), as of Dec 23, the value is 188.19. This value is within the healthy range. It has increased from 138.97 (Dec 22) to 188.19, marking an increase of 49.22.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 923.34. It has increased from 755.07 (Dec 22) to 923.34, marking an increase of 168.27.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 23, the value is 923.34. It has increased from 755.07 (Dec 22) to 923.34, marking an increase of 168.27.
For Dividend / Share (Rs.), as of Dec 23, the value is 5.00. This value exceeds the healthy maximum of 3. There is no change compared to the previous period (Dec 22) which recorded 5.00.
For Revenue From Operations / Share (Rs.), as of Dec 23, the value is 857.61. It has increased from 813.23 (Dec 22) to 857.61, marking an increase of 44.38.
For PBDIT / Share (Rs.), as of Dec 23, the value is 247.35. This value is within the healthy range. It has increased from 165.77 (Dec 22) to 247.35, marking an increase of 81.58.
For PBIT / Share (Rs.), as of Dec 23, the value is 232.34. This value is within the healthy range. It has increased from 150.14 (Dec 22) to 232.34, marking an increase of 82.20.
For PBT / Share (Rs.), as of Dec 23, the value is 231.62. This value is within the healthy range. It has increased from 162.89 (Dec 22) to 231.62, marking an increase of 68.73.
For Net Profit / Share (Rs.), as of Dec 23, the value is 173.18. This value is within the healthy range. It has increased from 123.34 (Dec 22) to 173.18, marking an increase of 49.84.
For PBDIT Margin (%), as of Dec 23, the value is 28.84. This value is within the healthy range. It has increased from 20.38 (Dec 22) to 28.84, marking an increase of 8.46.
For PBIT Margin (%), as of Dec 23, the value is 27.09. This value exceeds the healthy maximum of 20. It has increased from 18.46 (Dec 22) to 27.09, marking an increase of 8.63.
For PBT Margin (%), as of Dec 23, the value is 27.00. This value is within the healthy range. It has increased from 20.02 (Dec 22) to 27.00, marking an increase of 6.98.
For Net Profit Margin (%), as of Dec 23, the value is 20.19. This value exceeds the healthy maximum of 10. It has increased from 15.16 (Dec 22) to 20.19, marking an increase of 5.03.
For Return on Networth / Equity (%), as of Dec 23, the value is 18.75. This value is within the healthy range. It has increased from 16.33 (Dec 22) to 18.75, marking an increase of 2.42.
For Return on Capital Employeed (%), as of Dec 23, the value is 24.34. This value is within the healthy range. It has increased from 19.24 (Dec 22) to 24.34, marking an increase of 5.10.
For Return On Assets (%), as of Dec 23, the value is 15.59. This value is within the healthy range. It has increased from 13.62 (Dec 22) to 15.59, marking an increase of 1.97.
For Asset Turnover Ratio (%), as of Dec 23, the value is 0.85. It has decreased from 0.96 (Dec 22) to 0.85, marking a decrease of 0.11.
For Current Ratio (X), as of Dec 23, the value is 6.12. This value exceeds the healthy maximum of 3. It has increased from 5.92 (Dec 22) to 6.12, marking an increase of 0.20.
For Quick Ratio (X), as of Dec 23, the value is 5.53. This value exceeds the healthy maximum of 2. It has increased from 5.11 (Dec 22) to 5.53, marking an increase of 0.42.
For Inventory Turnover Ratio (X), as of Dec 23, the value is 5.40. This value is within the healthy range. It has increased from 5.21 (Dec 22) to 5.40, marking an increase of 0.19.
For Dividend Payout Ratio (NP) (%), as of Dec 23, the value is 2.88. This value is below the healthy minimum of 20. It has decreased from 4.05 (Dec 22) to 2.88, marking a decrease of 1.17.
For Dividend Payout Ratio (CP) (%), as of Dec 23, the value is 2.65. This value is below the healthy minimum of 20. It has decreased from 3.59 (Dec 22) to 2.65, marking a decrease of 0.94.
For Earning Retention Ratio (%), as of Dec 23, the value is 97.12. This value exceeds the healthy maximum of 70. It has increased from 95.95 (Dec 22) to 97.12, marking an increase of 1.17.
For Cash Earning Retention Ratio (%), as of Dec 23, the value is 97.35. This value exceeds the healthy maximum of 70. It has increased from 96.41 (Dec 22) to 97.35, marking an increase of 0.94.
For Interest Coverage Ratio (X), as of Dec 23, the value is 343.36. This value is within the healthy range. It has increased from 212.79 (Dec 22) to 343.36, marking an increase of 130.57.
For Interest Coverage Ratio (Post Tax) (X), as of Dec 23, the value is 241.41. This value is within the healthy range. It has increased from 141.97 (Dec 22) to 241.41, marking an increase of 99.44.
For Enterprise Value (Cr.), as of Dec 23, the value is 6,676.60. It has increased from 3,404.85 (Dec 22) to 6,676.60, marking an increase of 3,271.75.
For EV / Net Operating Revenue (X), as of Dec 23, the value is 9.82. This value exceeds the healthy maximum of 3. It has increased from 5.28 (Dec 22) to 9.82, marking an increase of 4.54.
For EV / EBITDA (X), as of Dec 23, the value is 34.05. This value exceeds the healthy maximum of 15. It has increased from 25.91 (Dec 22) to 34.05, marking an increase of 8.14.
For MarketCap / Net Operating Revenue (X), as of Dec 23, the value is 9.90. This value exceeds the healthy maximum of 3. It has increased from 5.35 (Dec 22) to 9.90, marking an increase of 4.55.
For Retention Ratios (%), as of Dec 23, the value is 97.11. This value exceeds the healthy maximum of 70. It has increased from 95.94 (Dec 22) to 97.11, marking an increase of 1.17.
For Price / BV (X), as of Dec 23, the value is 9.20. This value exceeds the healthy maximum of 3. It has increased from 5.76 (Dec 22) to 9.20, marking an increase of 3.44.
For Price / Net Operating Revenue (X), as of Dec 23, the value is 9.90. This value exceeds the healthy maximum of 3. It has increased from 5.35 (Dec 22) to 9.90, marking an increase of 4.55.
For EarningsYield, as of Dec 23, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Dec 22) which recorded 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Elantas Beck India Ltd as of March 12, 2025 is: ₹8,562.68

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Elantas Beck India Ltd is Overvalued by 13.39% compared to the current share price 9,886.00

Intrinsic Value of Elantas Beck India Ltd as of March 12, 2025 is: 10,079.16

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Elantas Beck India Ltd is Undervalued by 1.95% compared to the current share price 9,886.00

Last 5 Year EPS CAGR: 17.71%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 27.50%, which is a positive sign. The company has higher reserves (365.23 cr) compared to borrowings (0.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (459.92 cr) and profit (94.50 cr) over the years.	The stock has a high average Working Capital Days of 42.25, which may not be favorable. The stock has a high average Cash Conversion Cycle of 73.33, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Elantas Beck India Ltd:
1. Net Profit Margin: 20.19%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 24.34% (Industry Average ROCE: 15.97%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 18.75% (Industry Average ROE: 12.07%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 241.41
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 5.53
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 56.2 (Industry average Stock P/E: 56.58)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Elantas Beck India Ltd. is a Public Limited Listed company incorporated on 15/03/1956 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24222PN1956PLC134746 and registration number is 134746. Currently Company is involved in the business activities of Manufacture of paints and varnishes, enamels or lacquers. Company's Total Operating Revenue is Rs. 748.51 Cr. and Equity Capital is Rs. 7.93 Cr. for the Year ended 31/12/2024.

INDUSTRY	ADDRESS	CONTACT
Chemicals - Organic - Others	147, Mumbai-Pune Road, Pune Maharashtra 411018	CS.Elantas.Beck.India@altana.com https://www.elantas.com/beck-india

Management
Name	Position Held
Mr. Martin Babilas	Chairman
Mr. Srikumar Ramakrishnan	Managing Director
Mr. Nandkumar Dhekne	Director
Mr. Ranjal Laxmana Shenoy	Director
Mrs. Usha Rajeev	Director
Mr. Ravindra Kumar	Director
Mr. Sujjain Talwar	Director
Mr. Stefan Genten	Alternate Director

FAQ

What is the latest intrinsic value of Elantas Beck India Ltd?

The latest intrinsic value of Elantas Beck India Ltd as on 11 March 2025 is ₹8562.68, which is 13.39% lower than the current market price of 9,886.00, indicating the stock is overvalued by 13.39%. The intrinsic value of Elantas Beck India Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹7,837 Cr. and recorded a high/low of ₹14,980/7,601 during the current fiscal year 2024-2025. As of Jun 2024, the company has reserves of ₹799 Cr and total liabilities of ₹965 Cr.

What is the Market Cap of Elantas Beck India Ltd?

The Market Cap of Elantas Beck India Ltd is 7,837 Cr..

What is the current Stock Price of Elantas Beck India Ltd as on 11 March 2025?

The current stock price of Elantas Beck India Ltd as on 11 March 2025 is ₹9,886.

What is the High / Low of Elantas Beck India Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Elantas Beck India Ltd stocks is ₹14,980/7,601.

What is the Stock P/E of Elantas Beck India Ltd?

The Stock P/E of Elantas Beck India Ltd is 56.2.

What is the Book Value of Elantas Beck India Ltd?

The Book Value of Elantas Beck India Ltd is 1,094.

What is the Dividend Yield of Elantas Beck India Ltd?

The Dividend Yield of Elantas Beck India Ltd is 0.05 %.

What is the ROCE of Elantas Beck India Ltd?

The ROCE of Elantas Beck India Ltd is 23.0 %.

What is the ROE of Elantas Beck India Ltd?

The ROE of Elantas Beck India Ltd is 17.4 %.

What is the Face Value of Elantas Beck India Ltd?

The Face Value of Elantas Beck India Ltd is 10.0.